Drug development for neglected diseases - the trouble with FDA review vouchers

N Engl J Med. 2008 Nov 6;359(19):1981-3. doi: 10.1056/NEJMp0806684.

Author

Aaron S Kesselheim¹

Affiliation

¹ Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital, Harvard Medical School, Boston, USA.

PMID: 18987367
DOI: 10.1056/NEJMp0806684

No abstract available

MeSH terms

Developing Countries*
Drug Approval / economics
Drug Approval / legislation & jurisprudence*
Drug Approval / methods
Drug Discovery / legislation & jurisprudence*
Drug Industry
Government Regulation
Health Policy / economics
Humans
Parasitic Diseases / drug therapy*
Tropical Medicine
United States
United States Food and Drug Administration*